Herbas VPB

Print
EN | LT
Supplementary protection
LT - Gamybos būdas autologinių T ląstelių, naudotinų B ląstelių piktybinių navikų ir kitų vėžio rūšių gydymui, bei jų kompozicijos
EN - METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
SPC
(11) Number of the document
(68) Number of the document 3102609
(21) Application number for Supplementary Protection Certificate PA 2025 510
(22) Date of filing the application 2025-02-26
(41) Date of publication of the application 2025-03-10
Date of publication of SPC
(24) Date of coming into effect of SPC
Applicant
(71) The United States of America, as Represented by The Secretary, Department of Health and Human Services , Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, Bethesda, Maryland 20892-7788, US
Kite Pharma, Inc. , 2400 Broadway, Santa Monica, CA 90404, US
Grantee
(73) The United States of America, as Represented by The Secretary, Department of Health and Human Services , Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, Bethesda, Maryland 20892-7788, US
Kite Pharma, Inc. , 2400 Broadway, Santa Monica, CA 90404, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/20/1492, 2020-12-14
Name of the product protected by the basic patent
(95) Autologinės anti-CD19 transdukuotos CD3+ ląstelės (breksukabtageno autoleucelis)
Legal status
SPC application published
Last update date 2025-03-07